Richard Stone Net Worth

The estimated Net Worth of Richard B Stone is at least $59.8 Thousand dollars as of 4 March 2016. Richard Stone owns over 14,000 units of DarioHealth Corp stock worth over $18,777 and over the last 9 years he sold DRIO stock worth over $0. In addition, he makes $41,000 as Independent Director at DarioHealth Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Richard Stone DRIO stock SEC Form 4 insiders trading

Richard has made over 1 trades of the DarioHealth Corp stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 14,000 units of DRIO stock worth $49,840 on 4 March 2016.

The largest trade he's ever made was buying 14,000 units of DarioHealth Corp stock on 4 March 2016 worth over $49,840. On average, Richard trades about 583 units every 0 days since 2016. As of 4 March 2016 he still owns at least 23,768 units of DarioHealth Corp stock.

You can see the complete history of Richard Stone stock trades at the bottom of the page.

Richard Stone biography

Prof. Richard B. Stone serves as Independent Director of the Company. Prof. Stone has been active participant in early stage business enterprises as a director or investor, including technology and biotechnology companies. He currently serves on the board of directors of multiple technology companies, including Powermat, Espro-Accoustiguide Group, Wellsense Technologies, NanoX Imaging Plc, Illumigyn Ltd, Cardiologic Innovations, Quality Inflow Ltd., and Check-Cap. Since 1974, Prof. Stone has been a member of the faculty of Columbia Law School, where he held the Wilbur Friedman Chair in Tax Law for twenty years. In addition to basic and advanced tax courses, Prof. Stone has taught in the areas of contracts, business planning and real estate planning. Among other not-for-profit organizations he has been associated with, from 2011 to 2013, Prof. Stone served as Chairman of the Conference of Presidents of Major American Jewish Organizations. Prof. Stone began his career in 1967 in private practice in Washington, D.C, and thereafter joined the staff of the Solicitor General of the United States, where from 1969 to 1973 he was Assistant to the Solicitor General. He is a graduate of Harvard College and Harvard Law School. Stone is qualified to serve on our Board of Directors because of his legal expertise and experience with life sciences companies.

What is the salary of Richard Stone?

As the Independent Director of DarioHealth Corp, the total compensation of Richard Stone at DarioHealth Corp is $41,000. There are 8 executives at DarioHealth Corp getting paid more, with Erez Raphael having the highest compensation of $1,382,200.

How old is Richard Stone?

Richard Stone is 77, he's been the Independent Director of DarioHealth Corp since 2014. There are no older and 16 younger executives at DarioHealth Corp.

What's Richard Stone's mailing address?

Richard's mailing address filed with the SEC is 18 W. 18TH ST, 5TH FLOOR, , NEW YORK, NY, 10011.

Insiders trading at DarioHealth Corp

Over the last 9 years, insiders at DarioHealth Corp have traded over $4,057,564 worth of DarioHealth Corp stock and bought 2,163,162 units worth $794,618 . The most active insiders traders include Erez Raphael, Adam K Stern, and Yoav Shaked. On average, DarioHealth Corp executives and independent directors trade stock every 33 days with the average trade being worth of $20,360. The most recent stock trade was executed by Steven Charles Nelson on 5 September 2024, trading 15,000 units of DRIO stock currently worth $12,300.

What does DarioHealth Corp do?

DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform.

Complete history of Richard Stone stock trades at DarioHealth Corp

DarioHealth Corp executives and stock owners

DarioHealth Corp executives and other stock owners filed with the SEC include:

• Erez Raphael,
  Chief Executive Officer, Director
• Erez Raphael,
  CEO & Director
• Richard A. Anderson,
  Pres & GM of North America
• Dror Bacher,
  Chief Operating Officer
• Zvi Ben-David,
  Chief Financial Officer, Treasurer, Secretary
• Olivier Jarry,
  Senior Vice President - Strategy and Business Development
• Dror Bacher,
  Chief Operating Officer
• Zvi Ben David,
  CFO, Treasurer & Sec.
• Richard Stone,
  Independent Director
• Dennis McGrath,
  Independent Director
• Hila Karah,
  Independent Director
• Dennis Matheis,
  Director
• Omar Manejwala,
  Chief Medical Officer
• Barbara Stark,
  Senior Vice President, Head of Managed Markets
• Adam Stern,
  Director
• Yadin Shemmer,
  Independent Director
• Richard Anderson,
  President, General Manager - North America
• Allen Kamer,
  Independent Director
• Yoav Shaked,
  Independent Chairman of the Board
• Limor Drezner,
  VP HR & Chief of Staff
• Josh Fischer,
  Sr. VP of Operations & Compliance
• Yinon Amir,
  Head of Software Innovation
• Jean Christophe Muyl,
  Head of Commercialization North America
• Suzanne Bedell,
  VP of Marketing
• Claudia Levi,
  Content & Communications Mang.
• Dov Oppenheim,
  Co-Founder & Production Chief
• Olivier R. Jarry,
  Sr. VP of Strategy & Bus. Devel.
• Hod Rami Yehudiha,
  Director
• Glen Moller,
  Director
• Yalon Farhi,
  Director
• Malcolm Hoenlein,
  Director
• Ori Zanco,
  Director
• Yossi Bahagon,
  Director
• Shmuel Farhi,
  10% owner
• Yossef Balucka,
  CEO and President
• Oded Cohen,
  GM MSK
• Jon H. Kaplan,
  Director
• Tomer Ben Kiki,
  Chief Operating Officer
• Steven Charles Nelson,
  Chief Commercial Officer